Citation

  • Authors: Kong, D., Shen, Y., Liu, G., Zuo, S., Ji, Y., Lu, A., Nakamura, M., Lazarus, M., Stratakis, C. A., Breyer, R. M., Yu, Y.
  • Year: 2016
  • Journal: J Exp Med 213 2209-26
  • Applications: in vitro / DNA / jetPEI-Macrophage
  • Cell type: Mouse peritoneal macrophages
    Description: Mouse primary peritoneal macrophage

Abstract

The kinetic participation of macrophages is critical for inflammatory resolution and recovery from myocardial infarction (MI), particularly with respect to the transition from the M1 to the M2 phenotype; however, the underlying mechanisms are poorly understood. In this study, we found that the deletion of prostaglandin (PG) D2 receptor subtype 1 (DP1) in macrophages retarded M2 polarization, antiinflammatory cytokine production, and resolution in different inflammatory models, including the MI model. DP1 deletion up-regulated proinflammatory genes expression via JAK2/STAT1 signaling in macrophages, whereas its activation facilitated binding of the separated PKA regulatory IIalpha subunit (PRKAR2A) to the transmembrane domain of IFN-gamma receptor, suppressed JAK2-STAT1 axis-mediated M1 polarization, and promoted resolution. PRKAR2A deficiency attenuated DP1 activation-mediated M2 polarization and resolution of inflammation. Collectively, PGD2-DP1 axis-induced M2 polarization facilitates resolution of inflammation through the PRKAR2A-mediated suppression of JAK2/STAT1 signaling. These observations indicate that macrophage DP1 activation represents a promising strategy in the management of inflammation-associated diseases, including post-MI healing.

Pubmed